Results 241 to 250 of about 6,129,049 (301)

ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.
Andrea Henden   +13 more
wiley   +1 more source

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. [PDF]

open access: yesClin Microbiol Rev
Hoenigl M   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy